DH Stock — Definitive Healthcare Corp

Definitive Healthcare Corp (DH)

Updated October 16, 2026.

DH is a Stock. Total return is -97.7% over the past 5.1 years, 180.5 points behind SPY at 82.8%.

Definitive Healthcare provides a software-as-a-service platform delivering commercial intelligence on healthcare providers and their activities to biopharmaceutical, medical device, healthcare technology, and healthcare provider companies, as well as staffing firms, financial institutions, and marketing agencies. The company does not currently have an established distribution schedule. This stock may appeal to growth-oriented investors seeking exposure to healthcare software and data intelligence services.

DH performance versus SPY

Price and return data through 2026-10-16.

Total return is -97.7% over the past 5.1 years, 180.5 points behind SPY at 82.8%. Over the past year its total return — price change plus distributions reinvested — is -65.9%. Its deepest 1-year drawdown was 79.3%.

DH key facts

Asset type

Stock

Asset class

Equity

Inception date

09/15/2021

Distribution frequency

None

Last close

$1.00 (as of 2026-10-16)

Market cap

$106,744,713

Average volume

187834.0

Beta

1.396

Payout ratio

0.0%

Forward P/E

5.3163

EPS

$-1.61

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

DH risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 79.3%.

Who may consider DH — and who may not

It is a weaker fit for investors who need monthly cash flow (DH does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on DH

• All tickers starting with D

Tagged: Healthcare.

Frequently asked questions